Injecting and Sexual Networks and Sociodemographic Factors and Dual HIV Risk Among People Who Inject Drugs: A Cross-sectional Study in Kermanshah Province, Iran

Overview

Journal Addict Health

Date 2017 May 13

PMID 28496957

Citations 4

Authors

Mehdi Noroozi

Ali Mirzazadeh

Alireza Noroozi

Hamid Sharifi

Peter Higgs

Zahra Jorjoran-Shushtari

Ali Farhoudian

Farbod Fadai

Farahnaz Mohhamadi-Shahboulaghi

Bahram Armoon

Ahmad Hajebi

Omid Massah

Affiliations

Soon will be listed here.

Abstract

Background: Few studies suggest that social network factors, including size of sexual network may associate with drug-related and sexual high-risk behaviors. The objective of this study is to investigate injecting and sexual networks and sociodemographic factors that might be associated with dual HIV risk (DHR) among people who inject drug (PWID).

Methods: The data from a cross-sectional study of 455 PWID that were recruited through peer-referral sampling were used in this study. The data were collected using a structured questionnaire consisted of modules on sociodemographic characteristics, sexual and injection-related risk behaviors during 12 months before the interview. DHR was defined as engaged in both using a syringe previously used by other PWIDs and unprotected sex during last 12 months. Data analysis was performed with descriptive and logistic regression. In final model, we considered variables with P < 0.500 as statistically significant. Finally, reported adjusted odds ratio (AOR) and confidence interval (95% CI) for variables that were significant in the final model.

Findings: A total of 455 men who injected drugs participated in this study. The mean age ± standard deviation (SD) was 33.2 ± 7.3 (range 19-58) years. Overall, the prevalence of DHR In the last 12 months, 38% (95% CI: 18.3-51.2%). Multivariate model showed that regular visit to needle, syringe programs (NSPs) reduced odd of HDR to 50% when adjusted for other covariates, but still remained statistically significant (P < 0.050). The odds of reporting DHR was significantly higher in those ≥ 2 sex partners and injection partner (P < 0.010). Odds of DHR was higher (AOR: 2.3) among participants who had more than 2 injection per day but was not statistically significant (P > 0.050).

Conclusion: DHR was common in PWID in Kermanshah, Iran. Having multiple injecting and sexual partners increased the odds of engaging in dual risk behaviors, but regular visit of NSPs can reduce the DHR among PWID.

Citing Articles

Comprehensive analysis of the HIV/AIDS policy-making process in Iran.

Khodayari-Zarnaq R, Mosaddeghrad A, Nadrian H, Kabiri N, Ravaghi H Health Res Policy Syst. 2019; 17(1):69.

PMID: 31324185 PMC: 6642503. DOI: 10.1186/s12961-019-0466-6.

Hidden populations: discovering the differences between the known and the unknown drug using populations in the Republic of Georgia.

Gogia M, Lawlor C, Shengelia N, Stvilia K, Raymond H Harm Reduct J. 2019; 16(1):15.

PMID: 30755222 PMC: 6373035. DOI: 10.1186/s12954-019-0287-5.

Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran.

Esmaeili A, Shokoohi M, Danesh A, Sharifi H, Karamouzian M, Haghdoost A AIDS Behav. 2018; 23(6):1594-1603.

PMID: 30460664 PMC: 6527484. DOI: 10.1007/s10461-018-2345-5.

Social network and HIV risk behaviors in female sex workers: a systematic review.

Shushtari Z, Hosseini S, Sajjadi H, Salimi Y, Latkin C, Snijders T BMC Public Health. 2018; 18(1):1020.

PMID: 30115056 PMC: 6097207. DOI: 10.1186/s12889-018-5944-1.

References

Noroozi M, Mirzazadeh A, Noroozi A, Mehrabi Y, Hajebi A, Zamani S . Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran. Addict Health. 2016; 7(3-4):164-73. PMC: 4741237. View

Bastos F, Strathdee S . Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000; 51(12):1771-82. DOI: 10.1016/s0277-9536(00)00109-x. View

Coates T, Richter L, Caceres C . Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008; 372(9639):669-84. PMC: 2702246. DOI: 10.1016/S0140-6736(08)60886-7. View

Alipour A, Haghdoost A, Sajadi L, Zolala F . HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect. 2013; 89 Suppl 3:iii41-4. PMC: 3841763. DOI: 10.1136/sextrans-2013-051201. View

Strathdee S, Shoptaw S, Dyer T, Quan V, Aramrattana A . Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention. Curr Opin HIV AIDS. 2012; 7(4):320-5. PMC: 3646543. DOI: 10.1097/COH.0b013e32835369ad. View

Bruneau J, Lamothe F, Franco E, Lachance N, Desy M, Soto J . High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1998; 146(12):994-1002. DOI: 10.1093/oxfordjournals.aje.a009240. View

Neaigus A, Reilly K, Jenness S, Hagan H, Wendel T, Gelpi-Acosta C . Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City. AIDS Behav. 2013; 17(7):2501-9. DOI: 10.1007/s10461-013-0496-y. View

Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N . HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect. 2013; 89 Suppl 3:iii29-32. PMC: 3841768. DOI: 10.1136/sextrans-2013-051204. View

Hashemi Nazari S, Noroozi M, Soori H, Noroozi A, Mehrabi Y, Hajebi A . The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. Int J Drug Policy. 2016; 27:127-31. DOI: 10.1016/j.drugpo.2015.10.011. View

10.

De P, Cox J, Boivin J, Platt R, Jolly A . Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health. 2007; 85(1):77-89. PMC: 2430130. DOI: 10.1007/s11524-007-9225-z. View

11.

Iversen J, Topp L, Wand H, Maher L . Individual-level syringe coverage among Needle and Syringe Program attendees in Australia. Drug Alcohol Depend. 2011; 122(3):195-200. DOI: 10.1016/j.drugalcdep.2011.09.030. View

12.

Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari S . Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J. 2005; 2:19. PMC: 1266391. DOI: 10.1186/1477-7517-2-19. View

13.

Cao W, Treloar C . Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug Alcohol Rev. 2006; 25(5):439-44. DOI: 10.1080/09595230600891282. View

14.

Lowndes C, Alary M, Platt L . Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation. Sex Transm Dis. 2003; 30(1):46-8. DOI: 10.1097/00007435-200301000-00010. View

15.

Noroozi M, Nedjat S, Golestan B, Majdzadeh R . What are Differences between Non-injecting and Injecting Drug Addicts?. Int J Prev Med. 2012; 3(6):414-9. PMC: 3389439. View

16.

Latkin C, Vlahov D . Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction. 1998; 93(8):1191-7. DOI: 10.1046/j.1360-0443.1998.93811917.x. View

17.

Eshrati B, Asl R, Dell C, Afshar P, Millson P, Kamali M . Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J. 2008; 5:21. PMC: 2443130. DOI: 10.1186/1477-7517-5-21. View

18.

Neaigus A, Friedman S, Jose B, Goldstein M, Curtis R, Ildefonso G . High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 11(5):499-509. DOI: 10.1097/00042560-199604150-00011. View

19.

Hadland S, Marshall B, Kerr T, Qi J, Montaner J, Wood E . Suicide and history of childhood trauma among street youth. J Affect Disord. 2011; 136(3):377-80. PMC: 3288410. DOI: 10.1016/j.jad.2011.11.019. View

20.

McCoy C, Lai S, Metsch L, Messiah S, Zhao W . Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004; 14(8):535-42. DOI: 10.1016/j.annepidem.2003.10.001. View